Jiangsu, China

Xu Li

USPTO Granted Patents = 1 

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Xu Li - Innovator in Traditional Chinese Medicine

Introduction

Xu Li is a notable inventor based in Jiangsu, China, recognized for his contributions to the field of traditional Chinese medicine. His innovative approach combines ancient practices with modern scientific understanding, leading to the development of effective medicinal compositions.

Latest Patents

Xu Li holds a patent for a traditional Chinese medicine composition that includes active ingredients derived from various natural sources. This composition comprises at least 1600 parts of amino acids, 120 parts of gallic acid, 130 parts of liquiritin, and several other components, including baicalin and glycyrrhizic acid. The formulation is designed to provide antipyretic, anti-inflammatory, and antitussive effects, showcasing the potential of traditional remedies in contemporary healthcare.

Career Highlights

Xu Li is associated with Jiangsu Kanion Pharmaceutical Co., Ltd., where he has made significant strides in pharmaceutical innovation. His work emphasizes the importance of integrating traditional knowledge with modern technology to create effective health solutions.

Collaborations

Throughout his career, Xu Li has collaborated with esteemed colleagues such as Wei Xiao and Haibo Li. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of traditional medicine.

Conclusion

Xu Li's contributions to traditional Chinese medicine highlight the importance of innovation in healthcare. His patented compositions not only reflect a deep understanding of ancient practices but also pave the way for future advancements in medicinal applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…